Mark Woodward's Publications

About Mark Woodward's Publications

Senior Professorial Fellow, Professorial Unit
  • Chair of Statistics, Epidemiology and Women’s Health at Imperial College London
  • Professor of Medical Statistics, Faculty of Medicine, UNSW Sydney
  • PhD ,
  • FMedSci,
  • FAHMS,
  • FESC
  • Effect of randomised blood pressure lowering treatment and intensive glucose control on dementia and cognitive decline according to baseline cognitive function and other subpopulations of individuals with type 2 diabetes: Results from the ADVANCE trial

    Cerebral Circulation - Cognition and Behavior Date published:
  • Mixture analysis of associations between environmental and workplace toxins and liver damage and telomere length, stratified by race/ethnicity

    Journal of Environmental Sciences Date published:
  • Heavy metals are liver fibrosis risk factors in people without traditional liver disease etiologies

    Journal of Environmental Sciences Date published:
  • Performance of the revised World Health Organization cardiovascular disease risk prediction models for the Middle East and North Africa: a validation study in the Tehran Lipid and Glucose Study

    Journal of Clinical Epidemiology Date published:
  • The Clinical Implications of Slope of Glomerular Filtration Rate in Clinical Trials of Chronic Kidney Disease

    Clinical Journal of the American Society of Nephrology Date published:
  • A health economic evaluation of the multinational, randomized controlled CONVINCE trial: cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis

    Kidney International Date published:
  • Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset

    The Lancet Regional Health - Western Pacific Date published:
  • Diet Quality Indices, All-Cause Mortality, Cardiovascular Disease, and Dementia-Outcomes from the Australian Longitudinal Study on Women’s Health

    The Journal of Nutrition Date published:
  • STatin TReatment for COVID-19 to Optimise NeuroloGical recovERy (STRONGER): study protocol for a randomised, open label clinical trial in patients with persistent neurological symptoms after COVID-19 infection

    BMJ Open Date published:
  • Body Mass Index, Comorbidities, and Ambulatory Care Visits: The REGARDS Study

    Journal of the American Heart Association Date published:
  • Impact of Frailty on Antihypertensive Treatment in Older Adults

    Hypertension Date published:
  • Sex differences in risk factors for incident sepsis hospitalisations: a prospective cohort study using the UK Biobank

    The Journal of Infectious Diseases Date published:
  • Subacute Neurological Improvement Predicts Favorable Functional Recovery After Intracerebral Hemorrhage: INTERACT2 Study

    Stroke Date published:
  • Variations in sex differences in major cardiometabolic risk factors by age and menopause status: results from the UK Biobank

    Open Heart Date published:
  • Corticosteroid Effects in IgA Nephropathy by Baseline Proteinuria and Estimated GFR

    Kidney International Reports Date published:
  • Socioeconomic disparities and risk of recurrent cardiovascular events and cardiovascular disease-free life expectancy in patients with established cardiovascular disease

    European Journal of Preventive Cardiology Date published: